H1N1 Vaccine Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the H1N1 Vaccine Industry Market Size Be by 2025?
In the past few years, the H1N1 vaccine market has significantly expanded in size. The market is projected to rise from a value of $3.33 billion in 2024 to $3.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. This upward trend during the historic period can be traced back to factors such as past influenza epidemics, global health safety apprehensions, processes surrounding the development and approval of vaccines, worldwide immunisation drives, public health awareness programs, government finance and aid, as well as the flexibility of the pharmaceutical industry.

What's the Long-Term Growth Forecast for the H1N1 Vaccine Market Size Through 2029?
In the forthcoming years, the market size for the H1N1 vaccine is projected to experience robust growth, rising to "$4.69 billion in 2029" with a compound annual growth rate (CAGR) of 7.4%. The anticipated growth during the forecast duration can be credited to the studies on broad-spectrum vaccines, worldwide vaccine equality programs, reinforcement of public health resilience, fortification of global health governance, and the incorporation of H1N1 vaccination with regular immunization. Notable trends during the forecast period are global readiness for pandemics, influenza vaccination campaigns, advancements in vaccine development, research on cross-protection, worldwide health initiatives, upgrades in vaccine manufacturing technology, enlargement of production capacity, and data observation and surveillance.

View the full report here:
https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

What Are the Key Growth Drivers Fueling the H1N1 Vaccine Market Expansion?
The H1N1 vaccine market is predicted to expand due to heightened spending on research and development activities associated with immunology and vaccine production. Immunology facilitates the understanding of the immune system and is a vital component of biological and medical research. Vaccines and immunology play a crucial role in preventing infections and producing antibodies that combat these infections. Vaccines, particularly the H1N1 vaccine, enhance antibody creation, offering immunity against various diseases. For instance, mRNA COVID-19 vaccines were swiftly developed with the support of the NIH, a US-based agency's research, as of March 2023. By March 2022, over 577 million dosages had been delivered in the United States, saving approximately 2.4 million lives and averting 17 million hospitalizations. Hence, the surge in allocation for research and development activities concerning immunology and vaccines fuels the growth trajectory of the H1N1 vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp

What Are the Key Trends Driving H1N1 Vaccine Market Growth?
The rising prominence of strategic alliances amongst corporations is a noteworthy trend in the H1N1 (swine flu) vaccination market. Businesses operating within the H1N1 (swine flu) vaccination industry are centering their efforts on strategic partnerships to bolster their share in the market. For example, in August 2022, a substantial pharmaceutical firm and Open Orphan subsidiary hVIVO consented to a deal worth $123 million to manufacture a new variety of H1N1 influenza challenge virus. This move has enhanced the growth prospects of both entities in the sector.

How Is the H1N1 Vaccine Market Segmented?
The h1n1 vaccine market covered in this report is segmented -

1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination
3) By End Users: Hospitals, Clinics, Research And Diagnostic Laboratories, Other End Users

Subsegments:
1) By Inactivated Vaccine: Injectable Inactivated Vaccine, Intranasal Inactivated Vaccine
2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine, Intranasal Live Attenuated Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7881&type=smp

Which Companies Are Leading the Charge in H1N1 Vaccine Market Innovation?
Major companies operating in the H1N1 vaccine market are Sanofi SA, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Pfizer Inc., Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.

Which Regions Are Leading the Global H1N1 Vaccine Market in Revenue?
North America was the largest region in the H1N1 vaccine market in 2024. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7881

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.